Clinical trial / 2018
A defined plant-based diet for 4 weeks significantly reduced lipoprotein(a), other atherogenic lipoproteins, and inflammatory markers in overweight and obese adults.
In a secondary analysis of a trial, 31 overweight and obese adults with LDL cholesterol >100 mg/dL consumed a defined plant-based diet for 4 weeks. Significant reductions were observed for serum Lp(a) (-32.0 ± 52.3 nmol/L, P = 0.003), apolipoprotein B (-13.2 ± 18.3 mg/dL, P < 0.0005), LDL particles (-304.8 ± 363.0 nmol/L, P < 0.0005), and small-dense LDL cholesterol (-10.0 ± 9.2 mg/dL, P < 0.0005). Significant reductions were also seen in IL-6, total white blood cells, Lp-PLA2, hs-CRP, and fibrinogen (all P ≤ 0.004).
- Study type
- Secondary analysis of a trial (before-and-after / paired analysis)
- Who was studied
- 31 overweight and obese individuals with low-density lipoprotein cholesterol >100 mg/dL
- What was measured
- Serum Lp(a), atherogenic lipoproteins, and inflammatory biomarkers
THE PAPER
Consumption of a defined, plant-based diet reduces lipoprotein(a), inflammation, and other atherogenic lipoproteins and particles within 4 weeks.
Najjar RS, Moore CE, Montgomery BD. Clin Cardiol, 2018.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.